Inspire Medical Systems, Inc. Foreign Currency Transaction Gain Loss Realized After Tax
Inspire Medical Systems, Inc. (INSP) reported Foreign Currency Transaction Gain Loss Realized After Tax of $1.00 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-13.
Financial Statements › Income Statement › Other Income
us-gaap:ForeignCurrencyTransactionGainLossRealizedAfterTax · last filed 2026-02-13
- Inspire Medical Systems, Inc. foreign currency transaction gain loss realized after tax for the quarter ending 2025-12-31 was $0.00.
- Inspire Medical Systems, Inc. foreign currency transaction gain loss realized after tax for the quarter ending 2025-09-30 was -$100.00K, a 200.00% decline year-over-year.
- Inspire Medical Systems, Inc. foreign currency transaction gain loss realized after tax for the quarter ending 2025-06-30 was $500.00K.
- Inspire Medical Systems, Inc. foreign currency transaction gain loss realized after tax for the quarter ending 2025-03-31 was $600.00K.
- Inspire Medical Systems, Inc. foreign currency transaction gain loss realized after tax for fiscal 2025 was $1.00M.
- Inspire Medical Systems, Inc. foreign currency transaction gain loss realized after tax for fiscal 2024 was -$900.00K.
- Inspire Medical Systems, Inc. foreign currency transaction gain loss realized after tax for fiscal 2023 was -$200.00K.
- Inspire Medical Systems, Inc. foreign currency transaction gain loss realized after tax for fiscal 2022 was -$100.00K.
| Period end | Foreign Currency Transaction Gain Loss Realized After Tax 3 month | Foreign Currency Transaction Gain Loss Realized After Tax 3 month as first filed | Foreign Currency Transaction Gain Loss Realized After Tax 6 month | Foreign Currency Transaction Gain Loss Realized After Tax 6 month as first filed | Foreign Currency Transaction Gain Loss Realized After Tax 9 month | Foreign Currency Transaction Gain Loss Realized After Tax 9 month as first filed | Foreign Currency Transaction Gain Loss Realized After Tax 12 month | Foreign Currency Transaction Gain Loss Realized After Tax 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | -$100.00K derived: sum of 2 quarters · filed 2026-02-13 | $400.00K derived: sum of 3 quarters · filed 2026-02-13 | $1.00M 10-K · filed 2026-02-13 | ||||
| 2025-09-30 | -$100.00K 10-Q · filed 2025-11-03 | $400.00K derived: sum of 2 quarters · filed 2025-11-03 | $1.00M 10-Q · filed 2025-11-03 | $200.00K derived: sum of 4 quarters · filed 2026-02-13 | ||||
| 2025-06-30 | $500.00K 10-Q · filed 2025-08-04 | $1.10M 10-Q · filed 2025-08-04 | $300.00K derived: sum of 3 quarters · filed 2026-02-13 | $400.00K derived: sum of 4 quarters · filed 2026-02-13 | ||||
| 2025-03-31 | $600.00K 10-Q · filed 2025-05-05 | -$200.00K derived: sum of 2 quarters · filed 2026-02-13 | -$100.00K derived: sum of 3 quarters · filed 2026-02-13 | -$200.00K derived: sum of 4 quarters · filed 2026-02-13 | ||||
| 2024-12-31 | -$800.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | -$700.00K derived: sum of 2 quarters · filed 2026-02-13 | -$800.00K derived: sum of 3 quarters · filed 2026-02-13 | -$900.00K 10-K · filed 2026-02-13 | ||||
| 2024-09-30 | $100.00K 10-Q · filed 2025-11-03 | $0.00 derived: sum of 2 quarters · filed 2025-11-03 | -$100.00K 10-Q · filed 2025-11-03 | $0.00 derived: sum of 4 quarters · filed 2026-02-13 | ||||
| 2024-06-30 | -$100.00K 10-Q · filed 2025-08-04 | -$200.00K 10-Q · filed 2025-08-04 | $200.00K 10-Q · filed 2024-08-06 | -$100.00K derived: sum of 3 quarters · filed 2026-02-13 | -$300.00K derived: sum of 4 quarters · filed 2026-02-13 | |||
| 2024-03-31 | -$100.00K 10-Q · filed 2025-05-05 | $0.00 derived: sum of 2 quarters · filed 2026-02-13 | -$200.00K derived: sum of 3 quarters · filed 2026-02-13 | -$100.00K derived: sum of 4 quarters · filed 2026-02-13 | ||||
| 2023-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | -$100.00K derived: sum of 2 quarters · filed 2026-02-13 | $0.00 derived: sum of 3 quarters · filed 2026-02-13 | -$200.00K 10-K · filed 2026-02-13 | $200.00K 10-K · filed 2024-02-09 | |||
| 2023-09-30 | -$200.00K 10-Q · filed 2024-11-04 | $200.00K 10-Q · filed 2023-11-07 | -$100.00K derived: sum of 2 quarters · filed 2024-11-04 | -$300.00K 10-Q · filed 2024-11-04 | $300.00K 10-Q · filed 2023-11-07 | -$500.00K derived: sum of 4 quarters · filed 2025-02-10 | ||
| 2023-06-30 | $100.00K 10-Q · filed 2024-08-06 | $0.00 10-Q · filed 2024-08-06 | -$300.00K derived: sum of 3 quarters · filed 2025-02-10 | -$200.00K derived: sum of 4 quarters · filed 2025-02-10 | ||||
| 2023-03-31 | $0.00 10-Q · filed 2024-05-07 | -$400.00K derived: sum of 2 quarters · filed 2025-02-10 | -$300.00K derived: sum of 3 quarters · filed 2025-02-10 | -$200.00K derived: sum of 4 quarters · filed 2025-02-10 | ||||
| 2022-12-31 | -$400.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-10 | -$300.00K derived: sum of 2 quarters · filed 2025-02-10 | -$200.00K derived: sum of 3 quarters · filed 2025-02-10 | -$100.00K 10-K · filed 2025-02-10 | $100.00K 10-K · filed 2024-02-09 | |||
| 2022-09-30 | $100.00K 10-Q · filed 2023-11-07 | $200.00K derived: sum of 2 quarters · filed 2023-11-07 | $300.00K 10-Q · filed 2023-11-07 | |||||
| 2022-06-30 | $100.00K 10-Q · filed 2023-08-01 | $200.00K 10-Q · filed 2023-08-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |